ReviewFrontiers in chemistry2023
Multi-and many-objective optimization: present and future in
Review in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- AI-Driven Synthesis in Medicinal Chemistry: Integrating Large Language Models, Robotic Automation, and Sustainability Metrics to Accelerate Drug Discovery.Medicinal research reviews · 2026Review
- Multi-Endpoint Prediction of Bioactivity and ADMET Properties Coupled with Multi-Objective Optimization in Molecular Descriptor Space for Candidate ERα Antagonists.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Multi-objective optimization in the context of generative chemistry.Nature communications · 2026Review
- MOZAIC: compound growth via in silico reactions and global optimization using Conformational Space Annealing.Bioinformatics (Oxford, England) · 2026Article
- In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition.Biomolecules · 2026Article
- A review of recent advances in generative artificial intelligence models for biomolecular sciences.Acta pharmaceutica Sinica. B · 2026Review
- Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms.Computational and structural biotechnology journal · 2026Review
- Large Language Models for Controllable Multi-property Multi-objective Molecule Optimization.Findings of ACL. EMNLP. Conference on Empirical Methods in Natural Language Processing · 2025Article
- In Search of Beautiful Molecules: A Perspective on Generative Modeling for Drug Design.Journal of chemical information and modeling · 2025Review
- Artificial intelligence approaches for anti-addiction drug discovery.Digital discovery · 2025Review
- A Multi-Objective Molecular Generation Method Based on Pareto Algorithm and Monte Carlo Tree Search.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Integrate & balance aspects for safe and sustainable innovation: Needs analysis on SSbD categories and product development stage requirements to cover the entire life cycle.Computational and structural biotechnology journal · 2025Review
- Self-Driving Laboratories for Chemistry and Materials Science.Chemical reviews · 2024Review
- Integrating transformers and many-objective optimization for drug design.BMC bioinformatics · 2024Article
- DrugGym: A testbed for the economics of autonomous drug discovery.bioRxiv : the preprint server for biology · 2024Article
- Drug repurposing and phenotypic screening: innovative strategies for treating ultra-rare disorders.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.